Neuros Medical

Raised $56M in a Series D round, announced 9 July 2025.

Total raised
$56M

Latest round Series DCountry United StatesSector Health

Round

$56MSeries D, 9 July 2025

Funds US commercialization and further development of Altius.

Amount
$56M
Stage
Series D
Announced
9 July 2025
Lead
EQT Life Sciences
Other investors
US Venture Partners, Amzak Health, Osage University Partners, Sectoral Asset Management
Use of funds
Funds US commercialization and further development of Altius.
Checked
Amount and date matched across 2 press sources
Sources
Neuros Medical raises $56M Series D (date approx) massdevice.com
Neuros Medical raises $56M Series D (date approx) pulse2.com
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Maker of the FDA-cleared Altius nerve-block system for post-amputation pain.

Based in
United States
Sector
Health
Website
neurosmedical.com ↗

Links

Website
neurosmedical.com ↗

Questions

How much has Neuros Medical raised?

Neuros Medical raised $56M in a Series D round, announced on 9 July 2025.

Who invested in Neuros Medical?

EQT Life Sciences led. Investors include EQT Life Sciences, US Venture Partners, Amzak Health, Osage University Partners and Sectoral Asset Management.